Prognostic value of circulating tumor cells (CTC) in metastatic breast cancer (MBC): Correlation with immunohistochemically defined molecular subtypes and metastatic disease sites.

被引：1
|
作者：
Giordano, A.
Giuliano, M.
Hsu, L.
Handy, B. C.
Ueno, N. T.
Andreopoulou, E.
Alvarez, R. H.
Valero, V.
Hortobagyi, G. N.
Cristofanilli, M.
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.1000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1000
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Circulating tumor DNA (ctDNA) as a molecular monitoring tool in metastatic breast cancer (MBC)
    Austin, Laura Katherine
    Fortina, Paolo
    Sebisanovic, Dragan
    Siew, LaiMun
    Zapanta, Aubrey
    Talasaz, AmirAli
    Cristofanilli, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Molecular characterization of circulating tumor DNA in Chinese metastatic breast cancer (mBC) patients
    Yu, J.
    Li, H.
    Zhang, S.
    Wang, A.
    Zhao, Z.
    Liu, X-R
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [33] Detection of circulating tumor cells (CTCs) is a prognostic factor in first-line metastatic breast cancer (MBC)
    Cristofanilli, M
    Reuben, JM
    Fritsche, HA
    Hayes, DF
    Budd, TG
    Ellis, MJ
    Stopeck, A
    Miller, CM
    Matera, J
    Allard, JW
    Terstappen, LWMM
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S225 - S225
  • [34] Correlation of circulating tumor cells (CTCs) with peripheral blood leukocytes to predict outcome in metastatic breast cancer (MBC).
    De Giorgi, Ugo
    Mego, Michal
    Scarpi, Emanuela
    Giordano, Antonio
    Giuliano, Mario
    Valero, Vicente
    Alvarez, Ricardo H.
    Ueno, Naoto T.
    Cristofanilli, Massimo
    Reuben, James M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Prognostic Value of Circulating Tumor Cells (CTC) in HER-2 Positive Metastatic Breast Cancer (MBC) Patients (pts) Treated with Anti-HER2-Based Therapy
    Giuliano, M.
    Giordano, A.
    Handy, B. C.
    Ueno, N. T.
    Alvarez, R. H.
    Hortobagyi, G. N.
    Reuben, J. M.
    Valero, V.
    Cristofanilli, M.
    [J]. CANCER RESEARCH, 2010, 70
  • [36] Predictive and prognostic value of circulating tumor DNA (ctDNA) compared to circulating tumor cells (CTC) in a prospective cohort of metastatic breast cancer patients: The UCBG COMET trial
    Pierga, Jean-Yves
    Silveira, Amanda
    Girard, Elodie
    Lorgis, Veronique
    Tanguy, Marie-Laure
    Albaud, Benoit
    Tredan, Olivier
    Dubot, Coraline
    Hego, Caroline
    Jacot, William
    Goncalves, Anthony
    Debled, Marc
    Levy, Christelle
    Ferrero, Jean-Marc
    Jouannaud, Christelle
    Mouret-Reynier, Marie-Ange
    Dalenc, Florence
    Baulande, Sylvain
    Lemonnier, Jerome
    Berger, Frederique
    Bidard, Francois-Clement
    Proudhon, Charlotte
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [37] The prognostic impact of circulating tumor cells in subtypesof metastatic breast cancer
    Wallwiener, M.
    Hartkopf, A. D.
    Baccelli, I.
    Riethdorf, S.
    Schott, S.
    Pantel, K.
    Marme, F.
    Sohn, C.
    Schuetz, F.
    Trumpp, A.
    Rack, B.
    Aktas, B.
    Solomayer, E-F
    Mueller, V.
    Janni, W.
    Schneeweiss, A.
    Fehm, T. N.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 17 - 18
  • [38] Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) longitudinal monitoring of metastatic breast cancer (MBC).
    Costa, Ricardo Lima Barros
    Rossi, Giovanna
    Mu, Zhaomei
    Austin, Laura Katherine
    Rademaker, Alfred
    Gradishar, William John
    Santa-Maria, Cesar Augusto
    Jain, Sarika
    Flaum, Lisa E.
    Giles, Francis J.
    Yang, Hushan
    Cristofanilli, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer
    Banys-Paluchowski, M.
    Schneck, H.
    Blassl, C.
    Schultz, S.
    Meier-Stiegen, F.
    Niederacher, D.
    Krawczyk, N.
    Ruckhaeberle, E.
    Fehm, T.
    Neubauer, H.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2015, 75 (03) : 232 - 237
  • [40] Circulating tumor cells (CTCs) and prognostic stratification in metastatic breast cancer (MBC): need for a modification of the AJCC staging system?
    Dawood, S.
    Broglio, K.
    Reuben, J.
    Handy, B.
    Han, X.
    Ginsberg, C.
    Remus, L.
    Sun, X.
    Islam, R.
    Kau, S. W.
    Fritsche, H.
    Valero, V.
    Ueno, N.
    Hortobagyi, G. N.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 587 - 587
12345